Search

Your search keyword '"Goodfellow, Paul"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Goodfellow, Paul" Remove constraint Author: "Goodfellow, Paul" Database Complementary Index Remove constraint Database: Complementary Index
86 results on '"Goodfellow, Paul"'

Search Results

1. Characterization of mismatch‐repair/microsatellite instability‐discordant endometrial cancers.

2. Elliptical Forms: Abstract Algorithmic Objects.

3. Reply to "Mismatch repair and microsatellite instability—Recommendation for an optimal test strategy".

4. Channelling the Unknown: Noise in Art Ecosystems.

5. Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?

6. Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.

7. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis.

8. Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.

9. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.

10. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.

11. The artwork as an ecological object.

13. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.

14. Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.

16. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.

17. MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.

18. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

19. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.

20. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

21. Identification of endometrial cancer methylation features using combined methylation analysis methods.

22. MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair.

24. Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.

25. Novel APC promoter and exon 1B deletion and allelic silencing in three mutation-negative classic familial adenomatous polyposis families.

26. Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.

27. Polymerase ɛ ( POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing.

28. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.

29. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

31. Glycogen Synthase Kinase 3ß Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer.

32. CMS: A Web-Based System for Visualization and Analysis of Genome-Wide Methylation Data of Human Cancers.

33. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

34. Use of mutation profiles to refine the classification of endometrial carcinomas.

35. FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features.

36. Lower Uterine Segment Involvement is Associated with Poor Outcomes in Early-Stage Endometrioid Endometrial Carcinoma.

37. Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML.

38. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.

39. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome.

44. Low Allele Frequency of MLH1 D132H in American Colorectal and Endometrial Cancer Patients.

47. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Catalog

Books, media, physical & digital resources